Virus-free gene therapy for HIV shows promise

| | July 11, 2012
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

An experimental gene therapy for HIV may actually be easier—and even safer—than experts originally hoped. Experimenting with zinc finger nucleases (ZFNs), researchers at the Scripps Research Institute in La Jolla, California, have discovered it’s possible to cut out an undesirable “middle man”—a virus (not HIV) that carries the gene-altering payload to cells in the body. Until now, such viral vectors were considered a necessary element of gene therapy.  

View the original article here: Virus-Free Gene Therapy for HIV Shows Promise – AIDSmeds.com HIV/AIDS Treatment News

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend